Peter T. Nieh

Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

David M. Schuster, John R. Votaw, Peter T. Nieh et al. · PubMed · 2007 · 275 citations

Medicine, Nuclear Medicine, Oncology +17

Hyperspectral imaging and quantitative analysis for prostate cancer detection

Hamed Akbari, Luma V. Halig, David M. Schuster et al. · Journal of Biomedical Optics · 2012 · 265 citations · Full text

Medicine, Oncology, Urology +17

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine ( ¹⁸ F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer

Tore Bach‐Gansmo, Cristina Nanni, Peter T. Nieh et al. · The Journal of Urology · 2016 · 180 citations

Medicine, Oncology, Urology +17

Anti-3-[ ¹⁸ F]FACBC Positron Emission Tomography-Computerized Tomography and ¹¹¹ In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial

David M. Schuster, Peter T. Nieh, Ashesh B. Jani et al. · The Journal of Urology · 2013 · 171 citations

Medicine, Nuclear Medicine, Oncology +16

Detection of Recurrent Prostate Carcinoma with<i>anti</i>-1-Amino-3-¹⁸F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and¹¹¹In–Capromab Pendetide SPECT/CT

David M. Schuster, Bital Savir-Baruch, Peter T. Nieh et al. · Radiology · 2011 · 149 citations

Medicine, Nuclear Medicine, Radiology +17